RRBP1 promotes osimertinib resistance by activating fatty acid oxidation-dependent metabolic and immune reprogramming in EGFR-Mutant lung adenocarcinoma

Biochemical Pharmacology 2026

View at publisher

Authors: Yajie Huang, Yaozhong Zhang

DOI: 10.1016/j.bcp.2026.118158

Cited by: 1

References: 38

Fields of Study & Subjects

Ferroptosis and cancer prognosis Cancer Lipids and Metabolism Immune cells in cancer

References 38